Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2017 by University Hospital, Brest
Sponsor:
Collaborators:
Central Hospital, Nancy, France
Institut National de la Santé Et de la Recherche Médicale, France
Information provided by (Responsible Party):
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT01848639
First received: May 3, 2013
Last updated: May 4, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2024
  Estimated Primary Completion Date: June 2023 (Final data collection date for primary outcome measure)